Thymus capitatus represents 1 of the 5 Tunisian species of the genus Thymus, which has long-standing use for flavouring and preserving several food products. Its constituents have been reported to endow antimicrobial properties, but little is known about their antiviral activities. The aim of this study was to examine the antiviral activity of pure compounds from the most bioactive inhibitory T. capitatus extract in vitro against herpes simplex virus Type 2 (HSV-2) infection and to identify their mechanism of action. Either the extracts or the essential oil exert inhibitory activity against HSV-2 infection, with the ethanolic extract showing the lowest EC 50 value (2.3 μg/ml). Three pure compounds were then isolated from the ethanolic extract and investigated for their antiviral activity. β-sitosterol showed the most favourable selectivity index and both cinnamaldehyde and carvacrol exerted moderate antiviral effect. Investigation of the mechanism of action revealed that all three compounds directly inactivated the infectivity of the virus particles. These findings suggest the use of T. capitatus ethanolic extract as source of anti-HSV-2 pure compounds and warrant further studies to evaluate their therapeutic potential.
| INTRODUCTION
The Thymus genus is considered to be one of the largest genera within the Lamiaceae family that includes approximately 350 species of perennial, aromatic herb, and subshrubs native mainly of Europe, Western Asia, and the Mediterranean regions (Stahl-Biskup & Saez, 2002) . Thymus capitatus (Hoffmanns & Link, Lamiaceae) represents one of the five Tunisian species of the genus Thymus, which has a long-standing use for flavouring and preserving several food products.
Its essential oil is used in the flavouring cough medicines and oral hygiene products as well as in cosmetic and perfume industry. As a medicinal plant, T. capitatus decoction and infusion have traditionally been considered as antispasmodic, carminative, tonic, antiseptic, and antitussive drugs (Chiej, 1984) . Numerous reports showed antibacterial, antifungal, antioxidant, and anti-inflammatory properties of T. capitatus extracts and essential oil, rich in carvacrol and thymol (Achour, Khelifi, Attia, Ferjani, & Noureddine Hellal, 2012; Iauk et al., 2015; Maissa & Walid, 2015; Mkaddem et al., 2010) . To date, extracts of several species of Thymus, as Thymus vulgaris and Thymus linearis, have been investigated for their anti-herpetic effect, even though the constituents responsible of the antiviral activity have not been yet identified (Koch, Reichling, Schneele, & Schnitzler, 2008; Nolkemper, Reichling, Stintzing, Carle, & Schnitzler, 2006; Rajbhandari et al., 2009; Schnitzler, Koch, & Reichling, 2007) . Herpes simplex virus Type 2 (HSV-2) is a sexually transmitted pathogen that infects about 417 million people aged 15-49 (11%) worldwide, causing genital infections (WHO, 2017) . Most of these infections are asymptomatic Abbreviations: AE, aqueous extracts; CC 50 , 50% cytotoxic concentrations; EC 50 , half maximal effective concentration; EE, ethanolic extract; EO, essential oil extract; HIV, human immunodeficiency virus; HSV-2, herpes simplex virus Type 2; MEM, eagle's minimal essential medium; MOI, multiplicity of infection; NMR, nuclear magnetic resonance; PFU, plaque-forming units; SI, selectivity index; T. capitatus, Thymus capitatus; TLC, thin-layer chromatography Chemical compounds: β-sitosterol (PubChemCID: 222284), cinnamaldehyde (PubChemCID: 6428895), carvacrol (PubChemCID: 10364).
but can also cause painful blisters or ulcers at the site of infection.
Symptomatic infections are most contagious, but sexual transmission can also occur in the absence of symptoms (Roizman, Knipe, & Whitley, 2007) . Of note, genital ulcer disease increases the risk of human immunodeficiency virus (HIV) acquisition because the mucosal damage induces local inflammation, following activation and recruitment of CD4 + HIV target cells (Corey, 2007; Feng, Qiu, Sang, Lorenzo, & Glasser, 2013; Freeman et al., 2006) . Although different anti-herpetic drugs are approved and used to treat acute symptomatic infections (acyclovir, penciclovir, and other guanine analogues), the development of new antivirals against HSV-2 is needed due to several drawbacks of available drugs. These include the emergence of drug resistant strains, the inability to eradicate latent infections, the poor availability, and the incomplete intestinal absorption (Cavalli et al., 2012; Kimberlin & Whitley, 2007 
| Chemicals
Eagle's minimal essential medium (MEM) and fetal calf serum were purchased from Gibco/BRL (Gaithersburg, MD, USA) and the antibiotic-antimycotic solution (Zell Shield) from Minerva Biolabs GmbH (Berlin, Germany). Acyclovir and heparin were purchased from Sigma-Aldrich (Milan, Italy).
| Cells and culture conditions
African green monkey fibroblastoid kidney cells (Vero, ATCC CCL-81)
were grown as monolayers in MEM supplemented with 10% heat inactivated fetal calf serum and 1% Zell Shield.
| Virus
A clinical isolate of HSV-1 and HSV-2 was kindly provided by Prof. M.
Pistello, University of Pisa, Italy. HSV strains were propagated, and when the cytopathic effect involved the whole monolayer, the infected cell suspension was collected, and the viral supernatant clarified. The virus stocks were aliquoted, titrated by plaque assay on Vero cells, and stored at −80°C. A HSV-2 strain with phenotypic resistance to acyclovir was generated by serial passage in presence of increasing concentrations of acyclovir, as previously described (Donalisio et al., 2016) .
| Extracts preparation
The ethanolic and aqueous extracts (EE and AE) were prepared as previously described (Boubaker-Elandalousi et al., 2014) . The essential oil (EO) was prepared by dissolving 100 g of dried plant material in 1 L of distilled water and then submitted to microwave-assisted hydro-distillation at 40°C during 4 hr, in a Clevenger type apparatus. Extracts were kept in a dark flask at 4°C until tested. Working solutions (25 mg ml −1 ) of EO and EE were dissolved in dimethyl sulfoxide. Aqueous extracts were prepared in a similar way by 24-hr maceration.
2.6 | Isolation of pure compounds from ethanolic extract of T. capitatus 2.6.1 | Isolation and identification of β-sitosterol
The EE (10 g) of the plant was suspended in n-hexane (50 ml), and the resulting mixture was centrifuged at 5,000 g for 3 hr then filtered. The filtrate was evaporated to dryness under vacuum, and the resulting waxy solid dissolved in a 1:1 mixture water: ethanol (50 ml) and extracted with n-hexane (5 × 10 ml), and this latter evaporated to dryness under vacuum. The obtained powder was subjected to purification on a silica gel column chromatography using hexane: dichloromethane 9:1 as the eluent. β-Sitosterol (25 mg, purity > 96.3% assayed by high-performance liquid chromatography [HPLC; Figure 1a ] following an already reported method [Kakade & Magdum, 2012] was obtained as a white solid, and its structure was confirmed by thin-layer chromatography (TLC) and nuclear magnetic resonance (NMR) spectroscopy by comparison with an authentic sample.
| Isolation and identification of cinnamaldehyde and carvacrol
The EE (0.5 g) of the plant was subjected to silica gel column chromatography using dichloromethane and 95% dichloromethane/5% methanol mixture as the eluents. Cinnamaldehyde (10 mg, purity > 97.4%
assayed by HPLC [ Figure 1b ]) was eluted first and obtained as yellowish oil, and its structure was confirmed by TLC and NMR spectroscopy by comparison with an authentic sample. Carvacrol (12 mg, purity > 96.7% assayed by HPLC [ Figure 1c ]) was eluted as the second spot and got as a yellowish oil, and its structure was confirmed by TLC and NMR spectroscopy by comparison with an authentic sample.
| Gas chromatography and HPLC analysis
Gas chromatography (GC) analysis of the essential oil have been accomplished following the same general procedure as recently reported (Ricci, Epifano, & Fraternale, 2017) . HPLC analysis were carried out using a Waters 600 HPLC system equipped with a Waters 
| Viability assay
Cell viability was measured using the MTS assay as described by Pauwels et al. (1988) . The effect on cell viability of the different concentrations was expressed as a percentage, by comparing absorbance of treated cells with that of cells incubated with culture medium supplemented with equal volume of dimethyl sulfoxide. The 50% cytotoxic concentrations (CC 50 ) and the 95% confidence intervals were determined using Prism software (Graph-Pad Software, San Diego, CA, USA).
| Anti-HSV inhibition assay
The effect of T. capitatus extracts, isolated compounds, or acyclovir on HSV infection was evaluated by plaque reduction assay (Novoa et al., 2016) . Vero cells were seeded in 24-well plates at a density of 
| Pretreatment assay
Cells were exposed to serial dilutions of pure compounds in a 24-well plate at 37°C for 2 hr. After washing, cells were infected with HSV-2 at 0.001 MOI for 2 hr, washed, and treated as for plaque reduction assay (Donalisio et al., 2016) .
| Attachment assay
Prechilled Vero cells were treated with β-sitosterol or heparin for 30 min at 4°C and then infected with HSV-2 at 0.004 MOI for 2 hr at 4°C in presence of the pure compound. After three washes with cold MEM to remove unbound virus, cells were overlaid with 1.2% methylcellulose and shifted to 37°C. After 24-hr incubation, cells were stained, and viral plaques counted (Alvarez et al., 2009; Alvarez, Habtemariam, Moneim, et al., 2015) .
| Entry assay
The HSV-2 at 0.004 MOI was adsorbed for 2 hr at 4°C on prechilled 
| Posttreatment assay
Vero cells monolayers in 24-well plate were infected with HSV-2 at 0.001 MOI for 2 hr at 37°C, followed by two gentle washes to remove unbound virus. Increasing concentrations of pure compounds were then added to cultures in 1.2% methylcellulose medium. Cells were treated as for plaque reduction assay (Donalisio et al., 2013 3 | RESULTS AND DISCUSSION
| Inhibitory activity of T. capitatus extracts against HSV-1 and HSV-2 infections
Within a project aiming at evaluating the antiviral potential of Tunisian endemic plants, we investigated the antiviral activity of T. capitatus AE and EE and EO against HSV-2 infection. To generate dose-response curves, assays were performed by treating cells in presence of decreasing concentrations of extracts (ranging from 100 to 0.13 μg/ml) before, during, and after viral infection. Twenty-four-hour post infection, the EC 50 was determined by comparing the number of viral plaques in treated and untreated wells, as described in Section 2. As reported in 
| Chemical characterization of extracts and essential oil
All the obtained phytopreparations (EO, EE, and AE) were screened in order to obtain the respective chemical fingerprint. The essential oil of T. capitatus has been analyzed by GC-MS using a well-established procedure by our group and employed several times in recent years for the analysis of essential oil (Ricci et al., 2017 ; Figure 2 ).
| Inhibitory activity of isolated compounds from T. capitatus ethanolic extract and their mechanism of action
Data reported in Table 1 indicate that the EE was the most active one against both viruses under investigation. So we decided to define its phytochemical composition by isolation and structural characterization of its main components. Three compounds were isolated from T. capitatus EE, β-sitosterol, cinnamaldehyde, and carvacrol, and they were tested for their ability to inhibit the replication of the main cause of genital herpes, HSV-2. All of them were active against HSV-2 infection in a dose-response manner, with EC 50 values of 2.7, 39.7, and 51.9 μM, respectively (Table 2) ; acyclovir was tested in parallel as a reference drug. Among these compounds, β-sitosterol showed the strongest inhibitory activity with a SI value of 76.2. This is an interesting result because, in a previous study, the same compound isolated from Euphorbia segetalis exerted very low HSV-2 plaque reduction (Madureira et al., 2003) . Our finding is in agreement with previous data that also showed a strong anti HSV-2 activity for β-sitosterol FIGURE 2 Gas chromatography chromatogram of Thymus capitatus essential oil mixture like an essential oil that in a certain way can modify key parameters relevant to the biological activity like solubility in the medium employed for the antiviral assays. Such an effect has been already described for other biologically active secondary metabolites (Bakkali, Averbeck, Averbeck, & Idaomar, 2008) .
To evaluate whether the antiviral activity of isolated compounds was correlated to virus sensitivity to acyclovir, similar experiments were performed using an acyclovir-resistant HSV-2 (EC 50 value of 336.9 μM for acyclovir). As reported in Table 2 , the resistant strain was susceptible to β-sitosterol, cinnamaldehyde, and carvacrol, with , and carvacrol (c) on infectious herpes simplex virus Type 2 (HSV-2) particles at 37°C for 0 or 2 hr. On the y-axis, the infectious titers are expressed as plaque-forming units per ml (PFU/ ml). Error bars represent standard error of the mean of three independent experiments. *p < .001 specific cell assays we carried out. As shown in Figure 4a , pretreatment of cells with both β-sitosterol and cinnamaldehyde did not produce any inhibitory effect indicating that upon treatment, the cells remained susceptible to viral infection (pretreatment assay). This finding excludes that the compounds could act by stably interacting with a cellular component(s) thereby preventing its/their interaction with viral glycoproteins. To evaluate the possibility that the inhibitory activity was due not only to a virucidal effect but also to the ability of β-sitosterol to inhibit early steps of the virus replicative cycle, attachment and entry assays were performed. As reported in Figure 4b ,c, a weak inhibitory activity, around 20-30%, was only observed when the cells were treated with a high dose of compounds (80 μM) in both assays, whereas a dose-response curve was obtained treating cells with heparin, a known inhibitor of attachment.
These findings ruled out any effect β-sitosterol and cinnamaldehyde on virus attachment and entry. Then we wished to investigate whether the compounds were able to block the cell-to-cell transmission of HSV-2 (posttreatment assay). When β-sitosterol and Finally, both β-sitosterol and cinnamaldehyde also reduced the viral titer, in a dose-response manner, when they were tested in a virus yield reduction assay, with EC 50 value of 3.64 and 8.41 μM, respectively ( Figure 5 ). These data indicate their ability to inhibit multiple cycles of viral replication at high doses thus limiting the production of viral progenies. Acyclovir was used as standard positive drug of this assay.
Taken together, such antiviral properties might be useful in the setting of a productive infection in vivo, where T. capitatus extracts or its antiviral compounds might be able to prevent both cell-to-cell spread, which represents a major route of transmission for HSV-2 in vivo, and the transmission of extracellular free virus, which is often present in the site of infection at high titers (Dingwell et al., 1994) .
In conclusion, this study reports on the anti-herpetic activity of
T. capitatus extracts and shows, for the first time, the ability of its isolated compounds β-sitosterol, cinnamaldehyde, and carvacrol to inhibit infection by acyclovir-responsive and acyclovir-resistant HSV-2 strains. The mechanism of action of pure compounds mainly consists in direct inactivation of HSV-2 extracellular particles along with a reduced cell-to-cell virus spread. Findings identified pure compounds from T. capitatus ethanolic extract as inhibitors of HSV-2 infection suggesting their potential for treatment of herpetic lesions.
